PlainRecalls
FDA Drug Moderate Class II Terminated

KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49

Reported: April 15, 2015 Initiated: January 23, 2015 #D-0482-2015

Product Description

KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49

Reason for Recall

Crystallization

Details

Recalling Firm
Hospira Inc.
Units Affected
HOSPIRA = 13,720,475 vials, NOVAPLUS = 1,528,500 vials
Distribution
U.S. Nationwide and International: Guam and Singapore.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49. Recalled by Hospira Inc.. Units affected: HOSPIRA = 13,720,475 vials, NOVAPLUS = 1,528,500 vials.
Why was this product recalled?
Crystallization
Which agency issued this recall?
This recall was issued by the FDA Drug on April 15, 2015. Severity: Moderate. Recall number: D-0482-2015.